Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (3) , 296-301
- https://doi.org/10.1016/0959-8049(94)00487-p
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancerClinical Oncology, 1991
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.Journal of Clinical Oncology, 1991
- Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.Journal of Clinical Oncology, 1991
- Prognostic factors in advanced epithelial ovarian cancerBritish Journal of Cancer, 1990
- Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookGynecologic Oncology, 1990
- Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival durationCancer, 1988
- COMPLETE REMISSION AT LAPAROTOMY: STILL A GOLD STANDARD IN OVARIAN CANCER?The Lancet, 1986
- Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancerGynecologic Oncology, 1985
- Microscopic disease at second-look laparotomy in advanced ovarian cancerCancer, 1985